Ignite Creation Date:
2025-12-24 @ 3:19 PM
Ignite Modification Date:
2026-02-20 @ 12:33 PM
Study NCT ID:
NCT02269592
Status:
RECRUITING
Last Update Posted:
2025-12-01
First Post:
2014-10-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
Sponsor:
Dana-Farber Cancer Institute
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Monoclonal Gammopathy of Undetermined Significance (MGUS) | View |
| None | Myelodysplastic Syndromes | View |
| None | Hematological Malignancies | View |
| None | B-cell Malignancy, Low-grade | View |
| None | Myelodysplastic Syndrome With Low-grade Lesions | View |
| None | IgG Monoclonal Gammopathy of Uncertain Significance | View |
| None | Smoldering Multiple Myeloma | View |
| None | Waldenstrom Macroglobulinemia | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | MGUS | View |
| None | Smoldering Myeloma | View |
| None | Acute Myeloid Leukemia | View |
| None | Waldenstrom Macroglobulinemia | View |
| None | Monoclonal Gammopathy of Undermined Significance | View |
| None | Monoclonal B cell lymphocytosis | View |
| None | Smoldering Multiple Myeloma | View |
| None | Myelodysplastic syndromes | View |